Evangelos Mourkas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evangelos Mourkas has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
- Ben Pascoe
Ineos Oxford Institute for Antimicrobial Research, Department of Biology, University of Oxford, Oxford, United Kingdom
31 shared publications - Samuel K. Sheppard
University of Oxford
24 shared publications - Matthew D. Hitchings
Swansea University
16 shared publications - Jessica Kate Calland
Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
14 shared publications - Guillaume Méric
Baker Heart and Diabetes Institute
9 shared publications - Keith A. Jolley
University of Oxford
9 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (4) , 711-714
Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics
: Because of the global increase in resistance of Campylobacter to both fluoroquinolones and macrolides, we explored phenotypic resistance using traditional Kirby–Bauer methods in human- and animal-derived Campylobacter isolates that were concurrently resistant to both azithromycin and ciprofloxacin to an expanded panel of antimicrobials, including clindamycin, fosfomycin, ampicillin and sulbactam, amoxicillin and clavulanic, fosfomycin, tigecycline, and imipenem. Of 235 Campylobacter isolates resistant to ciprofloxacin and azithromycin, more than 94.8% of Campylobacter jejuni and Campylobacter coli were resistant to clindamycin, 68.5% were resistant to ampicillin and sulbactam, 2.6% were resistant to amoxicillin and clavulanic, and 36.2% were resistant to fosfomycin. Less than 2% of isolates were resistant to tigecycline, and there was no observed resistance to imipenem. The results suggest that amoxicillin and clavulanic warrant further evaluation for use in Campylobacter enteritis in ambulatory patients, but it points to no clear alternative oral therapies. Study findings were reassuring in demonstrating continued universal susceptibility to carbapenems.
- 7 October 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (4) , 711-714
Open AccessPhenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics
: Because of the global increase in resistance of Campylobacter to both fluoroquinolones and macrolides, we explored phenotypic resistance using traditional Kirby–Bauer methods in human- and animal-derived Campylobacter isolates that were concurrently resistant to both azithromycin and ciprofloxacin to an expanded panel of antimicrobials, including clindamycin, fosfomycin, ampicillin and sulbactam, amoxicillin and clavulanic, fosfomycin, tigecycline, and imipenem. Of 235 Campylobacter isolates resistant to ciprofloxacin and azithromycin, more than 94.8% of Campylobacter jejuni and Campylobacter coli were resistant to clindamycin, 68.5% were resistant to ampicillin and sulbactam, 2.6% were resistant to amoxicillin and clavulanic, and 36.2% were resistant to fosfomycin. Less than 2% of isolates were resistant to tigecycline, and there was no observed resistance to imipenem. The results suggest that amoxicillin and clavulanic warrant further evaluation for use in Campylobacter enteritis in ambulatory patients, but it points to no clear alternative oral therapies. Study findings were reassuring in demonstrating continued universal susceptibility to carbapenems.
- Open Access
- 30 September 2026
- Published by Springer Nature in Research Square
Resistance architectures underpin the evolution of antimicrobial resistance in Acinetobacter baumannii
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical-priority hospital pathogen for which genome-based surveillance increasingly informs antimicrobial resistance (AMR) detection. However, AMR-gene carriage alone does not explain the magnitude of carbapenem resistance (CR) or the evolutionary success of the lineages carrying these genes. We analysed a 16-year clinical isolate collection within a global genomic framework to investigate how CR emerges, persists and spreads. Despite widespread carbapenemase carriage, carbapenem MICs varied markedly. We identified two recurrent Resistance Architectures: genomic configurations comprising distinct AMR genes, mobile genetic elements, associated genomic features and lineage backgrounds that converged on similar CR phenotypes. A globally disseminated IC2-associated bla OXA−23 architecture contrasted with a regionally enriched IC6-associated plasmid-borne bla OXA−72 architecture, yet both were associated with high-level CR. Our findings suggest that clinically successful carbapenem-resistant emerges through the assembly of compatible genomic architectures rather than AMR-gene acquisition alone, providing a framework for interpreting AMR evolution and improving genome-based surveillance.
- 30 September 2026
- Published by Springer Nature in Research Square
Open AccessResistance architectures underpin the evolution of antimicrobial resistance in Acinetobacter baumannii
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical-priority hospital pathogen for which genome-based surveillance increasingly informs antimicrobial resistance (AMR) detection. However, AMR-gene carriage alone does not explain the magnitude of carbapenem resistance (CR) or the evolutionary success of the lineages carrying these genes. We analysed a 16-year clinical isolate collection within a global genomic framework to investigate how CR emerges, persists and spreads. Despite widespread carbapenemase carriage, carbapenem MICs varied markedly. We identified two recurrent Resistance Architectures: genomic configurations comprising distinct AMR genes, mobile genetic elements, associated genomic features and lineage backgrounds that converged on similar CR phenotypes. A globally disseminated IC2-associated bla OXA−23 architecture contrasted with a regionally enriched IC6-associated plasmid-borne bla OXA−72 architecture, yet both were associated with high-level CR. Our findings suggest that clinically successful carbapenem-resistant emerges through the assembly of compatible genomic architectures rather than AMR-gene acquisition alone, providing a framework for interpreting AMR evolution and improving genome-based surveillance.
- Open Access
- 8 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0346097
The wild, wild west of plasmids: First insights into comparative genomics of Borrelia burgdorferi sensu lato
Lyme borreliosis is caused by species of the Borrelia burgdorferi sensu lato complex. Genospecies vary in human pathogenicity, reservoir host and tick vector adaptation. What causes these differences is currently unknown, but some answers are likely to be found within the fragmented genomes containing linear and circular plasmids (and even fusions). These plasmids are highly variable and challenging to reconstruct completely. We aimed to analyze plasmid presence/absence and to identify trends in plasmid numbers and/or types associated with specific ecological adaptations or pathogenic potentials. For this, we used the most complete, reliable, and currently available 86 B. burgdorferi s.l. genomes (30 newly sequenced, 56 publicly available) belonging to 21 of the 28 known species. The plasmid types per isolate vary from 6-21 (median: 12) and linear plasmid numbers (3–12, median: 7) are significantly higher than circular plasmids (2–11, median: 5). The only plasmids found in all isolates are lp54 and cp26 and only a few species- or population-specific plasmids are identified, demonstrating the high variability. Species with smaller plasmid counts (median < 11) tend to have fewer lp28 and cp32 plasmids than larger plasmid counts species (median ≥ 15). Significantly higher total and circular plasmid numbers are found in rodents-only compared to birds-only associated species. Interestingly, plasmid numbers are not significantly reduced in species associated with a single reservoir host/vector compared to multiple. Analyses of the plasmid-location of the vls/vlsE antigenic variation system highlighted the dynamic nature of B. burgdorferi s.l. plasmids. Surprisingly, whilst the plasmid repertoire of B. burgdorferi s.l. is very plastic and variable, our analyses rarely reveal plasmids associated with specific ecological adaptations or pathogenic potentials. However, some plasmids were more frequently found in one of the groups and will be of interest for gene-based analyses that will be required for further progress in this research area.
- 8 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0346097
Open AccessThe wild, wild west of plasmids: First insights into comparative genomics of Borrelia burgdorferi sensu lato
Lyme borreliosis is caused by species of the Borrelia burgdorferi sensu lato complex. Genospecies vary in human pathogenicity, reservoir host and tick vector adaptation. What causes these differences is currently unknown, but some answers are likely to be found within the fragmented genomes containing linear and circular plasmids (and even fusions). These plasmids are highly variable and challenging to reconstruct completely. We aimed to analyze plasmid presence/absence and to identify trends in plasmid numbers and/or types associated with specific ecological adaptations or pathogenic potentials. For this, we used the most complete, reliable, and currently available 86 B. burgdorferi s.l. genomes (30 newly sequenced, 56 publicly available) belonging to 21 of the 28 known species. The plasmid types per isolate vary from 6-21 (median: 12) and linear plasmid numbers (3–12, median: 7) are significantly higher than circular plasmids (2–11, median: 5). The only plasmids found in all isolates are lp54 and cp26 and only a few species- or population-specific plasmids are identified, demonstrating the high variability. Species with smaller plasmid counts (median < 11) tend to have fewer lp28 and cp32 plasmids than larger plasmid counts species (median ≥ 15). Significantly higher total and circular plasmid numbers are found in rodents-only compared to birds-only associated species. Interestingly, plasmid numbers are not significantly reduced in species associated with a single reservoir host/vector compared to multiple. Analyses of the plasmid-location of the vls/vlsE antigenic variation system highlighted the dynamic nature of B. burgdorferi s.l. plasmids. Surprisingly, whilst the plasmid repertoire of B. burgdorferi s.l. is very plastic and variable, our analyses rarely reveal plasmids associated with specific ecological adaptations or pathogenic potentials. However, some plasmids were more frequently found in one of the groups and will be of interest for gene-based analyses that will be required for further progress in this research area.
- Open Access
- 19 February 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 56, 101413
Genomic epidemiology of a 2023–2024 Oropouche virus disease outbreak in Iquitos, Peru: descriptive analysis of a case control study for acute febrile illness
- 19 February 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 56, 101413
Open AccessGenomic epidemiology of a 2023–2024 Oropouche virus disease outbreak in Iquitos, Peru: descriptive analysis of a case control study for acute febrile illness
- Open Access
- 31 May 2025
- Published by Elsevier in Next Research
- Vol. 2 (3)
Temporal and spatial variation of third-generation cephalosporin-resistant and ESBL-producing Escherichia coli in a Swedish urban water system
- 31 May 2025
- Published by Elsevier in Next Research
- Vol. 2 (3)
Open AccessTemporal and spatial variation of third-generation cephalosporin-resistant and ESBL-producing Escherichia coli in a Swedish urban water system
- Open Access
- 27 May 2025
- Published by Elsevier in Science of The Total Environment
- Vol. 985, 179742
Global distribution of antimicrobial resistance genes in Escherichia coli isolated from wild animals using genomes available in public databases
- 27 May 2025
- Published by Elsevier in Science of The Total Environment
- Vol. 985, 179742
Open AccessGlobal distribution of antimicrobial resistance genes in Escherichia coli isolated from wild animals using genomes available in public databases
- Open Access
- 13 March 2025
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 74 (3) , 001988
Genomic insights into extended-spectrum β-lactamase- and plasmid-borne AmpC-producing Escherichia coli transmission between humans and livestock in rural Cambodia
Introduction. The global spread of extended-spectrum cephalosporinase-producing Escherichia coli (producing extended-spectrum β-lactamase or plasmid-borne AmpC, hereafter ESC-Ec) is a major public health concern. Whilst extensively studied in high-income countries, the transmission pathways between humans and animals in low- and middle-income countries (LMICs) remain unclear. In rural Cambodia, the asymptomatic carriage and transmission dynamics of ESC-Ec between humans and animals living in close proximity are poorly understood, highlighting the need for targeted research in this area. Gap statement. An enhanced understanding of the genetic epidemiology of ESC-Ec can enable mitigation strategies to reduce the burden of disease and drug-resistant infections in LMIC settings. Aim. This study aimed to investigate the genetic relatedness and genotypic antibiotic resistance profiles of ESC-Ec strains from humans and livestock in rural Cambodia and to identify patterns of antimicrobial resistance (AMR) gene transmission between hosts and across households and villages. Methodology. Faecal samples were collected from 307 humans and 285 livestock in 100 households in or near Kampong Cham Province in rural Cambodia. From these samples, 108 ESC-Ec strains were subjected to whole-genome sequencing. Core genome MLST (cgMLST) and phylogenetic analysis determined genetic relationships between strains. All strains were screened for the presence of antibiotic resistance genes and plasmids. Results. Human and livestock isolates were assigned to six phylogroups, with phylogroup A being the most common (56.5%). MLST identified 50 sequence types (STs), 17 of which were shared between humans and animals, with ST155 being the most prevalent. cgMLST revealed 97 distinct cgMLST sequence types (cgST), indicating strain sharing between humans and animals. Additionally, AMR gene analysis showed widespread resistance, with genes from the bla CTX-M group detected in 84.2% of isolates. Notably, AMR genes such as aph(3'')-Ib–sul2 co-occurred in 50% of isolates. Finally, plasmid analysis identified IncF plasmids in 75.9% of isolates, likely facilitating AMR gene transmission across hosts. Conclusions. Our findings demonstrate that ESC-Ec strains and their AMR genes are transmitted between humans and livestock in rural Cambodia, likely driven by both clonal spread and plasmid-mediated horizontal gene transfer. These results highlight the urgent need for antimicrobial stewardship and infection control strategies to mitigate the spread of multidrug-resistant pathogens in both human and animal populations.
- 13 March 2025
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 74 (3) , 001988
Open AccessGenomic insights into extended-spectrum β-lactamase- and plasmid-borne AmpC-producing Escherichia coli transmission between humans and livestock in rural Cambodia
Introduction. The global spread of extended-spectrum cephalosporinase-producing Escherichia coli (producing extended-spectrum β-lactamase or plasmid-borne AmpC, hereafter ESC-Ec) is a major public health concern. Whilst extensively studied in high-income countries, the transmission pathways between humans and animals in low- and middle-income countries (LMICs) remain unclear. In rural Cambodia, the asymptomatic carriage and transmission dynamics of ESC-Ec between humans and animals living in close proximity are poorly understood, highlighting the need for targeted research in this area. Gap statement. An enhanced understanding of the genetic epidemiology of ESC-Ec can enable mitigation strategies to reduce the burden of disease and drug-resistant infections in LMIC settings. Aim. This study aimed to investigate the genetic relatedness and genotypic antibiotic resistance profiles of ESC-Ec strains from humans and livestock in rural Cambodia and to identify patterns of antimicrobial resistance (AMR) gene transmission between hosts and across households and villages. Methodology. Faecal samples were collected from 307 humans and 285 livestock in 100 households in or near Kampong Cham Province in rural Cambodia. From these samples, 108 ESC-Ec strains were subjected to whole-genome sequencing. Core genome MLST (cgMLST) and phylogenetic analysis determined genetic relationships between strains. All strains were screened for the presence of antibiotic resistance genes and plasmids. Results. Human and livestock isolates were assigned to six phylogroups, with phylogroup A being the most common (56.5%). MLST identified 50 sequence types (STs), 17 of which were shared between humans and animals, with ST155 being the most prevalent. cgMLST revealed 97 distinct cgMLST sequence types (cgST), indicating strain sharing between humans and animals. Additionally, AMR gene analysis showed widespread resistance, with genes from the bla CTX-M group detected in 84.2% of isolates. Notably, AMR genes such as aph(3'')-Ib–sul2 co-occurred in 50% of isolates. Finally, plasmid analysis identified IncF plasmids in 75.9% of isolates, likely facilitating AMR gene transmission across hosts. Conclusions. Our findings demonstrate that ESC-Ec strains and their AMR genes are transmitted between humans and livestock in rural Cambodia, likely driven by both clonal spread and plasmid-mediated horizontal gene transfer. These results highlight the urgent need for antimicrobial stewardship and infection control strategies to mitigate the spread of multidrug-resistant pathogens in both human and animal populations.
- Open Access
- 5 February 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (2) , e0205424
Sharing of cmeRABC alleles between C. coli and C. jejuni associated with extensive drug resistance in Campylobacter isolates from infants and poultry in the Peruvian Amazon
Campylobacter is a serious health threat because of the rapid progressive evolution of antimicrobial resistance and efficient transmission from zoonotic as well as human sources. Resistance to fluoroquinolones and macrolides is particularly concerning as this compromises the two most effective oral antibiotic agents currently available for human campylobacteriosis. Here, we report on the prevalence and worldwide distribution of the operon cmeRABC , which encodes an efflux pump conferring high levels of combined resistance to fluoroquinolones and macrolides in Campylobacter strains isolated from poultry ( n = 75) and children ( n = 177). These mutations were found to be highly prevalent in isolates from poultry (62.7%) and children (29.4%) in Iquitos, Peru. We investigated the population structure of genes in the cmeRABC operon and identified a potential genetic bottleneck for the cmeA and cmeB genes. While most cmeB alleles segregate by species, alleles associated with high resistance to fluoroquinolones and macrolides were found in both Campylobacter jejuni and Campylobacter coli . We inferred that the likely ancestry of these alleles was from C. jejuni and was later acquired by C. coli through recombination. Publicly accessible global genomic data from 16,120 Campylobacter genomes identified these mutations in approximately 6% of C. jejuni and C. coli isolates globally, with higher prevalence in samples from poultry in many countries, including Peru. Our findings suggest that these extensively drug-resistant Campylobacter strains originated from C. jejuni in poultry. IMPORTANCE: Antimicrobial resistance in Campylobacter is a growing public health concern, driven by the rapid evolution and zoonotic transmission of resistant strains. This study focuses on mutations in the cmeABC efflux pump, which confer high resistance to fluoroquinolones and macrolides, the two most effective oral antibiotics for human campylobacteriosis. By analyzing genomes from poultry and children in Iquitos, Peru, as well as global genomic data sets, we identified a significant prevalence of these resistance-associated mutations, particularly in poultry and children. Our findings suggest that these mutations originated in Campylobacter jejuni and spread to C. coli through recombination. Globally, these mutations are found in approximately 6% of isolates, with higher prevalence in poultry in multiple countries. This research underscores the critical role of genomic epidemiology in understanding the origins, evolution, and dissemination of antimicrobial resistance and highlights the need to address poultry as a reservoir for resistant Campylobacter .
- 5 February 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (2) , e0205424
Open AccessSharing of cmeRABC alleles between C. coli and C. jejuni associated with extensive drug resistance in Campylobacter isolates from infants and poultry in the Peruvian Amazon
Campylobacter is a serious health threat because of the rapid progressive evolution of antimicrobial resistance and efficient transmission from zoonotic as well as human sources. Resistance to fluoroquinolones and macrolides is particularly concerning as this compromises the two most effective oral antibiotic agents currently available for human campylobacteriosis. Here, we report on the prevalence and worldwide distribution of the operon cmeRABC , which encodes an efflux pump conferring high levels of combined resistance to fluoroquinolones and macrolides in Campylobacter strains isolated from poultry ( n = 75) and children ( n = 177). These mutations were found to be highly prevalent in isolates from poultry (62.7%) and children (29.4%) in Iquitos, Peru. We investigated the population structure of genes in the cmeRABC operon and identified a potential genetic bottleneck for the cmeA and cmeB genes. While most cmeB alleles segregate by species, alleles associated with high resistance to fluoroquinolones and macrolides were found in both Campylobacter jejuni and Campylobacter coli . We inferred that the likely ancestry of these alleles was from C. jejuni and was later acquired by C. coli through recombination. Publicly accessible global genomic data from 16,120 Campylobacter genomes identified these mutations in approximately 6% of C. jejuni and C. coli isolates globally, with higher prevalence in samples from poultry in many countries, including Peru. Our findings suggest that these extensively drug-resistant Campylobacter strains originated from C. jejuni in poultry. IMPORTANCE: Antimicrobial resistance in Campylobacter is a growing public health concern, driven by the rapid evolution and zoonotic transmission of resistant strains. This study focuses on mutations in the cmeABC efflux pump, which confer high resistance to fluoroquinolones and macrolides, the two most effective oral antibiotics for human campylobacteriosis. By analyzing genomes from poultry and children in Iquitos, Peru, as well as global genomic data sets, we identified a significant prevalence of these resistance-associated mutations, particularly in poultry and children. Our findings suggest that these mutations originated in Campylobacter jejuni and spread to C. coli through recombination. Globally, these mutations are found in approximately 6% of isolates, with higher prevalence in poultry in multiple countries. This research underscores the critical role of genomic epidemiology in understanding the origins, evolution, and dissemination of antimicrobial resistance and highlights the need to address poultry as a reservoir for resistant Campylobacter .
- Open Access
- 28 September 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 76, 102841
The epidemiology and impact of persistent Campylobacter infections on childhood growth among children 0–24 months of age in resource-limited settings
- 28 September 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 76, 102841
Open AccessThe epidemiology and impact of persistent Campylobacter infections on childhood growth among children 0–24 months of age in resource-limited settings
- Open Access
- 7 September 2024
- Published by Elsevier in Journal of Infection
- Vol. 89 (5) , 106265
Machine learning to attribute the source of Campylobacter infections in the United States: A retrospective analysis of national surveillance data
- 7 September 2024
- Published by Elsevier in Journal of Infection
- Vol. 89 (5) , 106265
Open AccessMachine learning to attribute the source of Campylobacter infections in the United States: A retrospective analysis of national surveillance data